🚀 Intro : The Paradigm Shift"The company that helped end a global pandemic with mRNA just declared war on humanity’s ultimate dread: cancer." A single headline shook the global biotech landscape overnight, sparking an explosive market surge: Moderna and Merck (MSD) announced groundbreaking Phase 3 success for their personalized mRNA cancer vaccine.Unlike conventional vaccines designed to preve..